Lapix Therapeutics Inc. — Form D
Lapix Therapeutics Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-05. The offering totals $5.0M, of which $2.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-08-05
- Form: D
- Accession: 0001947620-25-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.2M
- Remaining: $2.8M
- Minimum investment: $1K
- Investors: 10
- Date of first sale: 2025-07-21
- Revenue range: Decline to Disclose
- SEC file number: 021-553733
Issuer
- Name: Lapix Therapeutics Inc.
- CIK: 0001947620
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 271 Cambridge St., 2nd Floor, Cambridge, MA, 02141
- Phone: 8582264717
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Anas Fathallah | Director | Cambridge, MA |
| Anthony Gibney | Director | Cambridge, MA |
| Francisco Leon | Director | Philadelphia, PA |
| Henry McKinnell | Director | Cambridge, MA |
| Jason Norris | Director | Cambridge, MA |
| Anas Fathallah | Executive Officer | Cambridge, MA |
| Jason Norris | Executive Officer | Cambridge, MA |
Other filings by this issuer (4)
More